Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

PURPOSE: During the SARS-CoV-2 pandemic, national and international societies have recommended continuing biological agents in patients with immune-mediated inflammatory diseases (IMID) in the absence of SARS-CoV-2 symptoms. However, adherence to biological treatment might decrease, because these re...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Groef, Romy, de Jong, Pascal H P, Hijnen, Dirk Jan, van der Woude, Christien J, van Laar, Jan A M, van der Kuy, P Hugo M, Brugma, Jan-Dietert, Pasma, Annelieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869789/
https://www.ncbi.nlm.nih.gov/pubmed/36698858
http://dx.doi.org/10.2147/PPA.S392290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869789/
https://www.ncbi.nlm.nih.gov/pubmed/36698858
http://dx.doi.org/10.2147/PPA.S392290

Ejemplares similares